Xiao-Hong Shu
Overview
Explore the profile of Xiao-Hong Shu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Song X, Shu X, Wu M, Zheng X, Jia B, Kong Q, et al.
BMC Cancer
. 2018 Sep;
18(1):871.
PMID: 30176837
Background: Although our previous study revealed lumbar punctured resveratrol could remarkably prolong the survival of rats bearing orthotopic glioblastomas, it also suggested the administration did not completely suppress rapid tumour...
2.
Wang Q, Long Y, Hang A, Zan G, Shu X, Wang Y, et al.
Psychopharmacology (Berl)
. 2016 Apr;
233(12):2411-8.
PMID: 27113225
Rationale: Opioid receptors are implicated in the regulation of motivation and emotion. However, animal studies show that activation of κ opioid receptor produces contrasting mood-altering effects in models of anxiety-like...
3.
Zan G, Wang Q, Wang Y, Liu Y, Hang A, Shu X, et al.
Behav Brain Res
. 2015 Jun;
291:334-341.
PMID: 26049060
The association between morphine withdrawal and depressive-like symptoms is well documented, however, the role of dynorphin/κ opioid receptor system and the underlying neural substrates have not been fully understood. In...
4.
Shu X, Wang L, Li H, Song X, Shi S, Gu J, et al.
Neurotherapeutics
. 2015 Jan;
12(2):491-501.
PMID: 25588581
Resveratrol possesses anti-tumor activities against central nervous system (CNS) tumors in vitro but has not yet been used clinically due to its low bioavailability, particularly in the CNS. This study...
5.
Wu M, Li H, Yu L, Chen X, Kong Q, Song X, et al.
PLoS One
. 2014 Mar;
9(2):e89806.
PMID: 24587049
Conventional adjuvant chemotherapies for bladder transitional cell carcinomas (TCCs) may cause strong systemic toxicity and local irritation. Non-toxic resveratrol inhibits TCC cell growth but its feasibility in clinical management of...
6.
Sun Z, Shi S, Li H, Shu X, Chen X, Kong Q, et al.
Cancer Chemother Pharmacol
. 2013 Aug;
72(5):965-73.
PMID: 23989725
Purpose: To further elucidate the correlation of resveratrol sensitivities with biotransformation activities of human and rat glioblastoma cells for personalized anti-glioblastoma therapy. Methods: Resveratrol sensitivity of human U251 and rat...
7.
Sun Z, Li H, Shu X, Shi H, Chen X, Kong Q, et al.
FEBS J
. 2012 May;
279(13):2381-92.
PMID: 22540632
Glioblastoma multiforme (GBM) cells show different responses to resveratrol, for unknown reasons. Our data from human medulloblastoma cells and primary cultures of rat brain cells revealed an inverse correlation of...
8.
Fu Y, Wang Q, Ma J, Yang X, Wu M, Zhang K, et al.
Mol Oncol
. 2011 Dec;
6(1):48-61.
PMID: 22153617
Medulloblastoma cells exhibit varied responses to therapy by all-trans retinoic acid (RA). The underlying mechanism for such diverse effects however remains largely unclear. In this study, we attempted to elucidate...
9.
Shu X, Li H, Sun X, Wang Q, Sun Z, Wu M, et al.
PLoS One
. 2011 Nov;
6(11):e27484.
PMID: 22096581
Background: Trans-resveratrol rather than its biotransformed monosulfate metabolite exerts anti-medulloblastoma effects by suppressing STAT3 activation. Nevertheless, its effects on human glioblastoma cells are variable due to certain unknown reason(s). Methodology/principal...
10.
Xin X, Deng S, Zhang B, Huang S, Tian Y, Ma X, et al.
Nat Prod Commun
. 2011 Aug;
6(6):781-4.
PMID: 21815410
Biotransformation of deoxyandrographolide (1) by Alternaria alternata AS 3.4578 gave five derivatives identified by spectral methods including 2D NMR as the known dehydroandrographolide (2) and 9beta-hydroxy-dehydroandrographolide (3) and the new...